Pharmacovigilance practice and risk control of Traditional Chinese Medicine drugs in China: current status and future perspective.
about
Adverse events attributed to traditional Korean medical practices: 1999-2010The Traditional Medicine and Modern Medicine from Natural ProductsHerbal Hepatotoxicity: Clinical Characteristics and Listing CompilationChinese Herbal Medicine-induced Liver InjuryHerbal traditional Chinese medicine and its evidence base in gastrointestinal disordersThe quest for modernisation of traditional Chinese medicineDevelopment of an adverse events reporting form for Korean folk medicine.A New Perspective on Liver Injury by Traditional Chinese Herbs Such As Polygonum multiflorum: The Geographical Area of Harvest As an Important Contributory FactorUsage patterns and adverse experiences in traditional Korean medicine: results of a survey in South KoreaSafety surveillance of traditional Chinese medicine: current and futureHerbal hepatotoxicity in traditional and modern medicine: actual key issues and new encouraging stepsIdentification of NF-κB inhibitors in Qishenyiqi dropping pills for myocardial infarction treatment based on bioactivity-integrated UPLC-Q/TOF MS.Traditional Chinese Medicine Induced Liver InjuryAn overview on adverse drug reactions to traditional Chinese medicines.Outcome measures of chinese herbal medicine for hypertension: an overview of systematic reviews.Community Pharmacists' Perceptions about Pharmaceutical Care of Traditional Medicine Products: A Questionnaire-Based Cross-Sectional Study in Guangzhou, China.A great honor and a huge challenge for China: You-you TU getting the Nobel Prize in Physiology or Medicine.Professional ethics in complementary and alternative medicines in management of Parkinson's disease.The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safetyBiological activity and toxicity of the Chinese herb Magnolia officinalis Rehder & E. Wilson (Houpo) and its constituentsComplementary and alternative medicine in diabetes care.Potential genotoxicity of traditional chinese medicinal plants and phytochemicals: an overview.The classification and application of toxic Chinese materia medica.Review article: Herbal hepatotoxicity--an update on traditional Chinese medicine preparations.Green tea extract and the risk of drug-induced liver injury.Spectrum-effect relationships as a systematic approach to traditional chinese medicine research: current status and future perspectives.Whole Medical Systems versus the System of Conventional Biomedicine: A Critical, Narrative Review of Similarities, Differences, and Factors That Promote the Integration Process.Clinical pharmacy service practice in a Chinese tertiary hospital.Renal toxic ingredients and their toxicology from traditional Chinese medicine.Gentiana scabra Bunge. Formula for Herpes Zoster: Biological Actions of Key Herbs and Systematic Review of Efficacy and Safety.How Can Synergism of Traditional Medicines Benefit from Network Pharmacology?An automated technique to identify potential inappropriate traditional Chinese medicine (TCM) prescriptions.Dengzhanxixin injection for cerebral infarction: A systematic review and meta-analysis of randomized controlled trials.Effect of Maxing Shigan Tang on H1N1 Influenza A Virus-Associated Acute Lung Injury in Mice.Detecting drug-herbal interaction using a spontaneous reporting system database: an example with benzylpenicillin and qingkailing injection.Traditional Chinese Medicine (TCM) and Herbal Hepatotoxicity: RUCAM and the Role of Novel Diagnostic Biomarkers Such as MicroRNAs.Metals Content in Herbal Supplements.Interaction of the bioactive flavonol, icariin, with the essential human solute carrier transporters.Use and Safety of Anthroposophic Medicinal Products: An Analysis of 44,662 Patients from the EvaMed Pharmacovigilance Network.Reporting patterns of adverse drug reactions over recent years in China: analysis from publications.
P2860
Q24632841-0FBF5F00-58F5-4E13-A560-8409FFB751A9Q26748266-3443587B-8518-4BA7-AC64-2A8E32BA1AAFQ26748874-82B2AE23-3199-4EDF-BFFF-33A8C65D262FQ26781971-72B22AFE-326E-42AB-ADA5-B52ABDBF04CBQ26992265-E5C1EC99-50DE-49EE-87AA-54AB05A17651Q28292682-B60BA53B-BAEA-4C46-AAC8-5C378B6E58DCQ33697954-811A7E0D-0E89-431C-9F5A-8AE9AEA17FBAQ33812968-BDF11A24-CEB5-460D-8E52-5E538F85081CQ34454019-69D3B9E5-8988-44E7-B49F-10E614E2B87AQ35142633-519260D4-41FE-4F37-B7DF-1F74AA34EABAQ35531281-BD68C08F-45B2-45A4-9DF5-5D370A5BFD9FQ35595583-FAA60400-B43D-44CC-B309-F2CA30CD5FACQ35906003-CD918C1A-A319-4629-854E-C6F83601B7B0Q36125530-84D8CEF0-41F4-48D8-B37E-E41F9B8062FCQ36528480-F51BEDE1-3F94-4512-ACA5-0C86EFEE8D89Q36737774-0D5FDFFD-9C2E-4886-9488-67F9C144502BQ36906122-C10E1594-35BE-4629-A31E-3D3F8E708A7CQ37382886-87D42459-1860-44A7-B2A8-ABDB9639C6CFQ37459724-6FCE8851-695B-42AF-9A53-43696CCC71F5Q37720791-5A6A9E6E-6F70-4973-B218-0C0E33155822Q38044247-2E68F592-748E-4C3B-A63E-6071888C8FF2Q38082754-6CDB413F-23EA-40BC-967D-88F64FC913DFQ38110713-E09B8668-D38D-4836-8E33-4C4CF3D34239Q38213152-057775D7-60DA-469D-A04A-1C2A53AA40D9Q38260305-484AF4A1-A2B0-4190-AD7E-B3C8D38DE14AQ38265613-DED3F242-23F2-44AF-A01B-F264D0159AEAQ38369115-4579D7EB-5ACF-4CA7-A1C8-AEC874A635DCQ38604859-F23F8E98-6496-48BC-BDBD-D521C68E1025Q38670132-B03F19BD-C204-4387-81E5-34EAF90D3EE4Q39081801-30CEE5FC-05FF-4B78-8505-C33B9D790D8DQ39420720-80BD7BB2-840D-493E-BDD2-6C25AD7862D4Q39972477-3CB42E49-2F16-48D1-84A2-36BB7CFA6BECQ40087972-CA8C2FD6-F48F-4AB9-B4E2-3B2DB86B7419Q40217200-2A0FDB04-7A99-47E8-869E-81F037DA2077Q40753272-C775FC4C-F55D-41EC-9F07-8D9BB3CF93A3Q41747844-36BA3109-D240-40C9-8962-5034E11D8FB0Q42100872-793962D3-797A-43E0-8B06-29717EF2554AQ42708245-519931B9-0D65-445F-BEEF-F5BB47B6E01CQ45780127-42774B19-0ACC-400E-BAAF-BE11A402D965Q47447271-E5429DF0-0ED1-4526-9866-BB8E6988FECA
P2860
Pharmacovigilance practice and risk control of Traditional Chinese Medicine drugs in China: current status and future perspective.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Pharmacovigilance practice and ...... status and future perspective.
@en
Pharmacovigilance practice and ...... status and future perspective.
@nl
type
label
Pharmacovigilance practice and ...... status and future perspective.
@en
Pharmacovigilance practice and ...... status and future perspective.
@nl
prefLabel
Pharmacovigilance practice and ...... status and future perspective.
@en
Pharmacovigilance practice and ...... status and future perspective.
@nl
P2093
P1476
Pharmacovigilance practice and ...... status and future perspective.
@en
P2093
Debbie Shaw
Jingbo Yan
Kelvin Chan
Pierre Duez
Ronald Meyboom
Xiaohui Yang
Xinmin Liu
Zuguang Ye
P304
P356
10.1016/J.JEP.2012.01.058
P50
P577
2012-02-21T00:00:00Z